all news

Our partners are building great companies. We love to share their stories.

Tue, 17 Dec 2024 Associated Press

Amplifire Named to the 2025 GSV 150: A Top Transformational Growth Company in Digital Learning & Workforce Skills

Thu, 12 Dec 2024 Associated Press

Dewpoint Therapeutics and ConcertAI Announce the First Phase of their Translational Oncology Partnership

Wed, 11 Dec 2024 Business Wire

Noema Pharma extends Series B financing round, closing at CHF 130 Million ($147 Million)

Thu, 5 Dec 2024 Associated Press

Muna Therapeutics Announces Strategic Alliance with GSK to Accelerate Development of Novel Treatments for Alzheimer's Disease

Wed, 4 Dec 2024 Associated Press

QurAlis Doses First Patient With ALS in Phase 1 Clinical Trial Evaluating QRL-101, a First-in-Class Kv7 Precision Therapy for ALS

Fri, 22 Nov 2024 GlobeNewswire

FloQast Recognized as a Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Thu, 21 Nov 2024 Podimetrics

Podimetrics Ranked the 128th Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Thu, 21 Nov 2024 PRNewswire - FinancialContent

MedTech Innovator Announces the 2024 Mid-Stage Grand Prize and Value Award Winners

Tue, 19 Nov 2024 GlobeNewswire

2024 BioTech Breakthrough Awards Program Celebrates Groundbreaking Biotechnology Innovators Around the World

Fri, 15 Nov 2024 arsenalmedical.com

Arsenal Medical Launches EMBO-02 Study for NeoCast™ to Assess Treatment of Chronic Subdural Hematoma

Thu, 14 Nov 2024 GlobeNewswire

FloQast Honored with 2024 Tech Ascension Award for Best Compliance Solution

Wed, 13 Nov 2024 Business Wire

TRexBio Announces $84 Million Series B Financing to Advance Pipeline of First-in-Class Immunology Programs into Clinical Development

Wed, 13 Nov 2024 Business Wire

Podimetrics Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity Threats

Wed, 6 Nov 2024 linkedin.com

New England Venture Capital Association Announces Nominees for the 12th Annual NEVY Awards

Mon, 4 Nov 2024 ADVFN

Scholar Rock Announces New Preclinical Data for SRK-439 Showing Significant Lean Mass Increase and Enhanced Fat Mass Loss with Metformin

Mon, 4 Nov 2024 Associated Press

Boston Scientific Announces Agreement to Acquire Cortex, Inc.

Thu, 31 Oct 2024 Associated Press

Sunbird Bio Presents New Clinical Data Demonstrating Proprietary Alpha Synuclein Blood-Based Biomarkers Could Accurately Diagnose Parkinson’s Disease

Wed, 30 Oct 2024 Dewpoint Therapeutics

Major milestone for Dewpoint with first development candidate announced

Wed, 30 Oct 2024 Associated Press

Amplifire Welcomes Nitin K. Walia as New President

Thu, 24 Oct 2024 Business Wire

Dyno Therapeutics Forms New Strategic Partnership With Roche To Advance AAV Gene Therapy Vectors For Neurological Diseases

Thu, 24 Oct 2024 GlobeNewswire

Bayer and Dewpoint Therapeutics sign Licensing Agreement for Heart Disease Program

Thu, 24 Oct 2024 GlobeNewswire

Auron Presents New Preclinical Data for Lead Program AUTX-703 Across Multiple Cancer Types

Fri, 18 Oct 2024 The Pharma Letter

Dewpoint Therapeutics

Thu, 17 Oct 2024 EIN Presswire

Tiger Aesthetics™ Expands Regenerative Aesthetics Portfolio with Strategic Acquisition of Suneva Medical® Product Lines

Thu, 17 Oct 2024 PRNewswire - FinancialContent

ByHeart Expands into Walmart, Whole Foods Market, and Wegmans, Increasing Retail Presence Over 200% to Bring Next-Generation Baby Formula to Families Nationwide

Thu, 17 Oct 2024 GlobeNewswire

Noema Pharma Announces NOE-105 (gemlapodect) Phase 2a Study in Tourette Syndrome met Primary and all Key Secondary Endpoints

Wed, 16 Oct 2024 PR Newswire

Arbital Health and Quartet Health Partner to Expand Severe Mental Illness Value-Based Care Arrangements

Wed, 16 Oct 2024 Business Wire

Sunbird Bio Raises Additional $14 Million to Advance Broadest Blood-Based Diagnostic Platform in Alzheimer’s Disease and Other Neurological

Tue, 15 Oct 2024 Newswire

Seraxis Announces FDA IND Allowance for Clinical Study of SR-02 Replacement Islets for Type 1 Diabetes

Fri, 11 Oct 2024 GlobeNewswire

CAMP4 Announces Pricing of Initial Public Offering